View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. DPT Laboratories
4 July 2012

Renaissance Acquisition Holdings Acquires DPT Laboratories

Renaissance Acquisition Holdings, a portfolio company of RoundTable Healthcare Partners, announced today that it has acquired DPT Laboratories.

DPT, the industry leader for semi-solids and liquids, is based in San Antonio, TX, where it has research and development, as well as manufacturing facilities. It also is expanding its presence in the sterile and specialty products markets, with facilities in Lakewood, NJ, that specialize in the development and aseptic manufacturing of clinical trial material and commercial scale products to meet sterile requirements.

DPT headquarters and staff will continue to be located in San Antonio and its management team will remain in place, the companies announced. As a result of the transaction, DFB Pharmaceuticals, based in San Antonio and Fort Worth, TX, will maintain a meaningful interest in the combined business and will provide oversight and counsel through representation on the Renaissance Board of Directors.

"As we review investment opportunities, we look for outstanding companies that deliver a value-added proposition, with strong management teams and excellent reputations in the markets in which they compete," said Pierre Fréchette, president and CEO of Renaissance Acquisition Holdings.

"As a market leader in the contract development and manufacturing space, DPT’s experienced management team has established a world-class reputation in semi-solids and liquids, as well as a sterile business with an outstanding regulatory track record that is poised for significant growth. Partnering with DPT to invest in its continued growth and success is a perfect fit with our strategy of building companies for the long-term.

"Renaissance and its management team bring a depth of industry experience, including a specific understanding of the contract manufacturing and development space, along with a successful history of partnering with companies like ours to help them grow," said Paul Johnson, group president and COO of DPT.

"This partnership provides the resources we need to accelerate our long-term strategic plans, which include maximizing our semi-solid and liquid business in San Antonio, and achieving aggressive growth in our sterile and specialty products business in Lakewood."

Pharmaceutical drug product development can be an expensive and time-consuming process. Many challenges are faced by pharmaceutical development companies including developing a scaleable, marketable formulation,...
With the increased globalisation and complexity of the pharmaceutical supply chain, managing the sourcing of materials has become extremely challenging. Reducing time and costs are...
This paper describes the approach and benefits of using DPT Labs' QbD Scale Up service and follows the third paper in our Thought Leadership Series,...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology